Armata Pharmaceuticals, Inc. (ARMP) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Armata Pharmaceuticals, Inc. (ARMP) closed at USD 2.78 on 2026-10-14, a change of -44.3 % over the past year, with a market capitalization of USD 114.89M.

Armata Pharmaceuticals, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Armata Pharmaceuticals, Inc. key figures

Previous close

USD 2.78 (2026-10-14)

1-year change

-44.3 %

Market cap

USD 114.89M

Enterprise value

USD 404.89M

P/E ratio (trailing)

-0.59

P/E ratio (forward)

-1.52

EPS (trailing)

-5.27

EPS (forward)

-2.04

PEG ratio

n/a

Price to book

-0.50

Revenue growth

15.7 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

2.77

Employees

61

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; and AP-PA03 for Pseudomonas aeruginosa. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Armata Pharmaceuticals, Inc. and compare it with other stocks.